Gossamer Bio, Inc. (GOSS) Share-based Payment Arrangement, Expense USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Gossamer Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2024.
  • Gossamer Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $5.81 M, a 191% increase year-over-year.
  • Gossamer Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $32.3 M.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $28.5 M, a 33% decline from 2022.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $42.6 M, a 32.9% increase from 2021.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $32 M, a 17.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $32.3 M $5.81 M +$3.81 M +191% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $28.5 M $12.2 M +$710 K +6.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $27.8 M $6.16 M -$3.96 M -39.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $31.8 M $8.2 M -$1.8 M -18% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2 M -$8.98 M -81.8% May 5, 2023 10-Q 2024-05-07
Q1 2023 $33.6 M $8.13 M -$2.86 M -26% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $42.6 M $11.4 M +$3.79 M +49.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $38.8 M $10.1 M +$2.54 M +33.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $36.2 M $10 M +$1.95 M +24.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $34.3 M $11 M +$2.28 M +26.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $32 M $7.66 M -$5.02 M -39.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $37 M $7.59 M -$1.34 M -15% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $38.4 M $8.05 M -$846 K -9.51% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $39.2 M $8.71 M +$464 K +5.63% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $38.7 M $12.7 M +$5.82 M +84.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-17
Q3 2020 $32.9 M $8.92 M +$3.2 M +55.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $29.7 M $8.9 M +$3.76 M +73.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $26 M $8.24 M +$5.16 M +167% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $20.8 M $6.86 M -$3.94 M -36.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-03
Q3 2019 $24.8 M $5.73 M -$12.4 M -68.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $37.2 M $5.14 M +$3.77 M +274% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $33.4 M $3.09 M +$2.48 M +411% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $30.9 M $10.8 M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $18.2 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.37 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $605 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.